Twist Bioscience Corporation: Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications
Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Vivlion GmbH, a company providing next-generation CRISPR gRNA libraries and screening services for the global R&D market, today announced a collaboration for the generation of gRNA libraries for CRISPR applications. CRISPR\Cas is a powerful functional genomics tool used for a wide range of applications including genome engineering and target discovery for drug development. Research using CRISPR continues to accelerate into many different areas. This collaboration combines Twist s ability to generate highly uniform long oligos at scale with Vivlion s ability to translate these into equally highly uniform CRISPR libraries for the next generation of high-throughput CRISPR screenings, said Emily M. Lep